Business ยท National
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.ย
Verified Timeline
No verified timeline updates.
What is your view on โModerna raises 2026 outlook as CEO says newer vaccines are gaining tractionโ?
This is self-selected reader participation, not representative scientific polling.

